Evidence map›Paper›PMID 40657370›Full record

ArticleJournal of Cancer2025

Integrative Multi-Omics Analysis and Experimental Validation Identify SPOP as a Prognostic Biomarker and Immune Regulator in Lung Adenocarcinoma.

Yu Wang, Tao Jiang, Ziyou Lin, Peijun Dai, Wenxin Wei, Chengyuan Dong, Xuelin Zhang, Zhifeng Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yu WangDepartment of Hepatic Surgery, Third Affiliated Hospital of Naval Medical University, Shanghai, China.
Tao JiangDepartment of orthopedics, Third Affiliated Hospital of Naval Medical University, Shanghai, China.
Ziyou LinTongji University School of Medicine, Shanghai, China.
Peijun DaiDepartment of orthopedics, Third Affiliated Hospital of Naval Medical University, Shanghai, China.
Wenxin WeiDepartment of Hepatic Surgery, Third Affiliated Hospital of Naval Medical University, Shanghai, China.
Chengyuan DongShanghai TCM-Integrated Hospital, Shanghai university of TCM, Shanghai, China.
Xuelin ZhangDepartment of thoracic surgery, Huadong hospital, Shanghai, China.
Zhifeng ZhangDepartment of orthopedics, Third Affiliated Hospital of Naval Medical University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

lung adenocarcinomaprognostic biomarkerSPOPtumor immunity

Identifiers

PMID40657370
PMCPMC12244332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.